These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Design, synthesis and SAR of piperidyl-oxadiazoles as 11β-hydroxysteroid dehydrogenase 1 inhibitors. Xia G; You X; Liu L; Liu H; Wang J; Shi Y; Li P; Xiong B; Liu X; Shen J Eur J Med Chem; 2013 Apr; 62():1-10. PubMed ID: 23353742 [TBL] [Abstract][Full Text] [Related]
25. Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor. Hale C; Véniant M; Wang Z; Chen M; McCormick J; Cupples R; Hickman D; Min X; Sudom A; Xu H; Matsumoto G; Fotsch C; St Jean DJ; Wang M Chem Biol Drug Des; 2008 Jan; 71(1):36-44. PubMed ID: 18069989 [TBL] [Abstract][Full Text] [Related]
26. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1. Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements. Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427 [TBL] [Abstract][Full Text] [Related]
28. Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1. Sun W; Maletic M; Mundt SS; Shah K; Zokian H; Lyons K; Waddell ST; Balkovec J Bioorg Med Chem Lett; 2011 Apr; 21(7):2141-5. PubMed ID: 21334894 [TBL] [Abstract][Full Text] [Related]
29. Adamantane 11-beta-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction. Sorensen B; Rohde J; Wang J; Fung S; Monzon K; Chiou W; Pan L; Deng X; Stolarik D; Frevert EU; Jacobson P; Link JT Bioorg Med Chem Lett; 2006 Dec; 16(23):5958-62. PubMed ID: 16996734 [TBL] [Abstract][Full Text] [Related]
30. Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Sutin L; Andersson S; Bergquist L; Castro VM; Danielsson E; James S; Henriksson M; Johansson L; Kaiser C; Flyrén K; Williams M Bioorg Med Chem Lett; 2007 Sep; 17(17):4837-40. PubMed ID: 17600707 [TBL] [Abstract][Full Text] [Related]
31. Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors. Shah U; Boyle CD; Chackalamannil S; Baker H; Kowalski T; Lee J; Terracina G; Zhang L Bioorg Med Chem Lett; 2010 Mar; 20(5):1551-4. PubMed ID: 20149650 [TBL] [Abstract][Full Text] [Related]
32. Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1). Wu SC; Yoon D; Chin J; van Kirk K; Seethala R; Golla R; He B; Harrity T; Kunselman LK; Morgan NN; Ponticiello RP; Taylor JR; Zebo R; Harper TW; Li W; Wang M; Zhang L; Sleczka BG; Nayeem A; Sheriff S; Camac DM; Morin PE; Everlof JG; Li YX; Ferraro CA; Kieltyka K; Shou W; Vath MB; Zvyaga TA; Gordon DA; Robl JA Bioorg Med Chem Lett; 2011 Nov; 21(22):6693-8. PubMed ID: 21983444 [TBL] [Abstract][Full Text] [Related]
33. 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes. Böhme T; Engel CK; Farjot G; Güssregen S; Haack T; Tschank G; Ritter K Bioorg Med Chem Lett; 2013 Aug; 23(16):4685-91. PubMed ID: 23845218 [TBL] [Abstract][Full Text] [Related]
34. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold. Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980 [TBL] [Abstract][Full Text] [Related]
35. 3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitor. Lee Y; Shin YJ; Ahn SK Bioorg Med Chem Lett; 2014 Mar; 24(5):1421-5. PubMed ID: 24507919 [TBL] [Abstract][Full Text] [Related]
36. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors. Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152 [TBL] [Abstract][Full Text] [Related]
37. 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice. Zhang X; Zhou Z; Yang H; Chen J; Feng Y; Du L; Leng Y; Shen J Bioorg Med Chem Lett; 2009 Aug; 19(15):4455-8. PubMed ID: 19564108 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604 [TBL] [Abstract][Full Text] [Related]
39. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors. Lin H; Hu GX; Guo J; Ge Y; Liang G; Lian QQ; Chu Y; Yuan X; Huang P; Ge RS Bioorg Med Chem Lett; 2013 Aug; 23(15):4362-6. PubMed ID: 23800686 [TBL] [Abstract][Full Text] [Related]
40. Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluation. Patel JR; Shuai Q; Dinges J; Winn M; Pliushchev M; Fung S; Monzon K; Chiou W; Wang J; Pan L; Wagaw S; Engstrom K; Kerdesky FA; Longenecker K; Judge R; Qin W; Imade HM; Stolarik D; Beno DW; Brune M; Chovan LE; Sham HL; Jacobson P; Link JT Bioorg Med Chem Lett; 2007 Feb; 17(3):750-5. PubMed ID: 17110106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]